Ticker: BCYC

Bicycle Therapeutics plc (NASDAQ: BCYC) is a clinical-stage pharmaceutical company focusing on developing novel medicines known as Bicycle® molecules for diseases that lack effective treatments. Recent Developments: Announced a workforce reduction aimed at reducing operating costs by approximate...

Bicycle Therapeutics plc (NASDAQ: BCYC) has recently released its quarterly report ending March 31, 2025, revealing key aspects of its financial health and operational activities. Positive Highlights from the Income Statement: Collaboration revenue amounted to $9.977 million, despite a decrease ...